Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Lowes | LOW | Nov 22, 2024 | 264.68 | -0.20 |
LPL Financial | LPLA | Nov 22, 2024 | 326.85 | +1.12 |
LQR House | LQR | Nov 22, 2024 | 1.19 | +0.36 |
LSB Industries | LXU | Nov 22, 2024 | 8.95 | +1.59 |
LSI Industries | LYTS | Nov 22, 2024 | 20.60 | +1.83 |
Ltc Properties | LTC | Nov 22, 2024 | 38.87 | +0.44 |
Lucas GC | LGCL | Nov 22, 2024 | 1.02 | +16.21 |
Lucid Diagnostics | LUCD | Nov 22, 2024 | 1.00 | 0.00 |
Lucid Group | LCID | Nov 22, 2024 | 2.10 | +1.94 |
Lufax ADR | LU | Nov 22, 2024 | 2.35 | +0.43 |
Lululemon Athletica | LULU | Nov 22, 2024 | 317.11 | +0.63 |
Lulus Fashion Lounge | LVLU | Nov 22, 2024 | 1.24 | +2.48 |
Lumen Technologies | LUMN | Nov 22, 2024 | 7.88 | +0.38 |
Lument Finance Trust | LFT | Nov 22, 2024 | 2.57 | +0.78 |
Lument Finance Trust A Pref | LFT-A | Nov 22, 2024 | 22.45 | 0.00 |
Lumentum | LITE | Nov 22, 2024 | 89.09 | +4.06 |
Luminar Technologies A | LAZR | Nov 22, 2024 | 8.95 | -17.59 |
Lumos Pharma | LUMO | Nov 22, 2024 | 4.31 | -0.46 |
Luna Innovations | LUNA | Nov 22, 2024 | 1.86 | +13.41 |
Luokung Technology | LKCO | Nov 22, 2024 | 1.74 | +4.19 |
Luxfer | LXFR | Nov 22, 2024 | 14.22 | +1.72 |
LuxUrban Hotels | LUXH | Nov 22, 2024 | 1.40 | +6.87 |
Luxurban Hotels Pref | LUXHP | Nov 22, 2024 | 13.87 | -7.53 |
Lxp Industrial Trust | LXP | Nov 22, 2024 | 9.28 | +0.87 |
LXP Industrial Trust C Pref | LXP-C | Nov 22, 2024 | 50.36 | +2.65 |
Lyell Immunopharma | LYEL | Nov 22, 2024 | 0.95 | +3.64 |
Lyft A | LYFT | Nov 22, 2024 | 16.79 | +3.07 |
LyondellBasell Industries Nv A | LYB | Nov 22, 2024 | 83.87 | +1.29 |
Lyra Therapeutics | LYRA | Nov 22, 2024 | 0.19 | +3.90 |
Lytus Technologies | LYT | Nov 22, 2024 | 1.63 | +1.24 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.